«Vascular Endothelial Growth Factor Receptor-2

Below is an extended Vascular Endothelial Growth Factor Receptor-2 patents listing. Click here to return to the Vascular Endothelial Growth Factor Receptor-2 main in depth entry.

Patents :
US Patent No.	Title
6756055	Cationic lipid compositions targeting angiogenic endothelial cells
6867348	Methods and compositions for screening for angiogenesis modulating compounds
6869962	Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
6887468	Antibody kits for selectively inhibiting VEGF
6897207	Azaindoles
6924302	Substituted triazole diamine derivatives as kinase inhibitors
6958147	Use of VEGF-C to prevent restenosis
6967198	Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
7034105	FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
7045528	Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
7052705	Anti-angiogenic peptides
6852533	Purified populations of stem cells
6849721	Modifications of the VEGF receptor-2 protein and methods of use
6831075	Heterocyclic substituted pyrazolones
6756383	Heterocyclic derivatives of quinolinone benimidazoles
6759417	Heterocyclic compounds
6762194	Quinolinone derivatives
6764820	Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
6774237	Quinolinone derivatives
6784285	Modifications of the VEGF Receptor-2 Protein and methods of use
6794146	Modifications of the VEGF receptor-2 protein and methods of use
6800760	Quinolinone derivatives
6818220	Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
6828327	Macroheterocylic compounds useful as kinase inhibitors
7053107	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
7056509	Antibody methods for selectively inhibiting VEGF
7226908	Use of VEGF and homologues to treat neuron disorders
7252824	Anti-neovasculature preparations for cancer
7261876	Multivalent constructs for therapeutic and diagnostic applications
7300768	Enzymatic measurement of imatinib mesylate
7304045	Nanoparticles for targeting hepatoma cells
7317031	Substituted triazole diamine derivatives as kinase inhibitors
7329737	Antibodies that bind hK-1
7335774	Quinolinone derivatives
7342107	Cynomolgus prostate specific antigen
7368459	Heterocyclic compounds
7211240	Multivalent constructs for therapeutic and diagnostic applications
7205298	Substituted triazine kinase inhibitors
7196190	Methods and compositions for screening for angiogenesis modulating compounds
7064215	Indazole benzimidazole compounds
7070938	Method to detect modulators of VEGF kinase domain
7094424	Cationic lipid compositions targeting angiogenic endothelial cells
7109220	Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
7125542	Methods and compositions for treating conditions of the eye
7125714	Progenitor cell materials and methods
7132533	Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
7135171	Endothelial precursor cells for enhancing and restoring vascular function
7135192	Cationic lipid compositions targeting angiogenic endothelial cells
7138409	Heterocyclic compounds
7393667	Stereoselective reduction process for the preparation of pyrrolotriazine compounds

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.